Hebei Yuxing Bio-Engineering Co. Ltd

Last updated

Hebei Yuxing Bio-Engineering Co. Ltd is a Chinese active pharmaceutical ingredient (API) company that exports to the United States of America. [1] Recently, the US FDA issued a warning letter due to "evidence that the company was keeping incomplete documentation and did not adequately investigate instances of microbial contamination." [2]

Related Research Articles

<span class="mw-page-title-main">Novartis</span> Swiss-American multinational pharmaceutical corporation

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.

<span class="mw-page-title-main">GSK plc</span> British multinational pharmaceutical and biotechnology company

GSK plc is a British multinational pharmaceutical and biotechnology company with global headquarters in London. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK is the tenth largest pharmaceutical company and #294 on the 2022 Fortune Global 500, ranked behind other pharmaceutical companies China Resources, Sinopharm, Johnson & Johnson, Pfizer, Roche, AbbVie, Novartis, Bayer, and Merck Sharp & Dohme.

<span class="mw-page-title-main">Beijing Institute of Technology</span> Public university in China

The Beijing Institute of Technology, is a national public university located in Beijing, China. It was originally established as Natural Science Academy in 1940 in Yan'an, Shaanxi. The university is affiliated with the Ministry of Industry and Information Technology. It is part of the Double First Class University Plan, Project 985 and Project 211.

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.

<span class="mw-page-title-main">ZX Auto</span> Chinese motor vehicle manufacturer

Hebei Zhongxing Automobile Co Ltd, branded as ZX Auto, is a Chinese producer of SUVs and pick-up trucks. Co-owned by Tianye Automobile Group Co Ltd and Taiwan Unite Leading Co, it was established in 1999 and exports to the Middle East, Southeast Asia, Africa, and Central and South America. The company claims a per year production capacity of 110,000 units – a figure that could conflate engines and whole vehicles.

<span class="mw-page-title-main">Astellas Pharma</span> Japanese pharmaceutical company

Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. On February 5, 2020, the company announced management changes effective from April 1, 2020.

<span class="mw-page-title-main">Daiichi Sankyo</span> Japanese pharmaceutical company

Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 981.8 billion in revenue in 2019. The company owns the American biotechnology company Plexxikon, American pharmaceutical company American Regent, German biotechnology company U3 Pharma, and recently sold Ranbaxy Laboratories in India. Daiichi Sankyo Co., Ltd. is the producer of Benicar (Olmesartan), an angiotensin II receptor antagonist and top selling drug in the U.S. Global sales of Olmesartan in 2013 were 300.2 billion yen.

<span class="mw-page-title-main">Tiens Group</span> Company

Tiens Group is a Chinese multinational conglomerate and multi-level marketing company headquartered in Tianjin, China.

<span class="mw-page-title-main">Chugai Pharmaceutical Co.</span> Japanese pharmaceutical company

Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO.

2008 Chinese heparin adulteration, refers to heparin adulteration incidents that occurred in the United States of America in 2008. Pharmaceutical company Baxter International subcontracted the creation of precursor chemicals of heparin to Scientific Protein Laboratories, an American company with production facilities located in China. Scientific Protein Laboratories then used counterfeit precursors to create the chemicals ordered. Baxter then sold this adulterated heparin in the US, which killed 81 people, and left 785 severely injured. This caught the attention of the media and the USA Food and Drug Administration leading to numerous ongoing lawsuits.

<span class="mw-page-title-main">ARIAD Pharmaceuticals</span> Defunct oncology company

ARIAD Pharmaceuticals, Inc. was an American oncology company, now part of Takeda Oncology, which was founded in 1991 by Harvey J. Berger, M.D. and headquartered in Cambridge, Massachusetts. ARIAD engaged in the discovery, development, and commercialization of medicines for cancer patients.

<span class="mw-page-title-main">Ipca Laboratories</span> Indian multinational pharmaceutical company

Ipca Laboratories Limited is an Indian multinational pharmaceutical company based in Mumbai. It produces theobromine, acetylthiophene, and p-bromotoluene as active pharmaceutical ingredients (APIs). Ipca sells these APIs and their intermediates globally. It produces more than 150 formulations that include oral liquids, tablets, dry powders, and capsules.

Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company is a major producer of HIV antivirals, as well as gynaecology and blood therapeutic drugs.

The Port of Huanghua, also known as the Port of Cangzhou Huanghua is an artificial deep-water international seaport on the coast of Huanghua, Cangzhou Prefecture, Hebei, People's Republic of China. It is located on the south side of the Bohai Bay, 90 km from Cangzhou city. Huanghua port is one of the largest and fastest growing ports in North China, with a throughput of 171.03 million tons of total cargo in 2013, an increase of 35.42% year on year.

Gilchrist & Soames is a Somerset, New Jersey-based marketer of English-themed in-room toiletry hotel amenities. The company also maintains an office in Aldermaston, West Berkshire.

Cheng Fong Chemical Co. Ltd is a Chinese active pharmaceutical ingredient (API) company that exports to the United States of America. In September 2016, the US FDA issued a warning letter "following a five-day inspection in April 2016 that found the company failed to appropriately maintain its facilities and investigate reports of foreign particles in finished batches." According to the FDA, Cheng Fong officials told investigators "that the rooms had never been cleaned.".

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.

<span class="mw-page-title-main">BioNTech</span> German biotechnology company

References

  1. Mezher, Michael (27 September 2016). "The Rooms Have Never Been Cleaned': Two New FDA Warning Letters for Chinese Manufacturers". RAPS. Retrieved 28 September 2016.
  2. "Hebei Yuxing Bio-Engineering Co Ltd 9/6/16 - Warning Letter 320-16-31". US FDA. 6 September 2016. Retrieved 28 September 2016.